Table 1.
Factorb | Value for BMI groupc |
P valued | ||||
---|---|---|---|---|---|---|
Total cohort | Underweight | Normal | Overweight | Obese | ||
BMI, kg/m2 | 25.2 (3.5) | 17.4 (1.1) | 22.6 (1.6) | 26.9 (1.4) | 32.6 (2.1) | |
Demographics | ||||||
Age, yr | 28.9 (6.8) | 24.7 (4.4) | 27.9 (6.7) | 29.9 (6.9) | 31.0 (6.8) | <0.001 |
No. (%) male | 1,053 (96) | 9 (69) | 522 (96) | 434 (97) | 88 (95) | <0.001 |
Ethnicity [no. (%)] | 0.02 | |||||
White/non-Hispanic | 487 (44) | 7 (54) | 264 (49) | 186 (42) | 30 (32) | |
African American | 439 (40) | 5 (38) | 207 (38) | 182 (41) | 45 (48) | |
Hispanic/Latino | 107 (10) | 1 (8) | 37 (7) | 56 (12) | 13 (14) | |
Other | 64 (6) | 0 (0) | 35 (6) | 24 (5) | 5 (5) | |
HIV-related factors | ||||||
Seroconversion window, yr | 1.3 (0.7) | 1.2 (0.8) | 1.3 (0.7) | 1.3 (0.7) | 1.4 (0.7) | 0.83 |
No. (%) with HIV diagnosis in HAART era | 700 (64) | 7 (54) | 308 (57) | 309 (69) | 76 (82) | <0.001 |
Baseline HIV-RNA, copies/ml [no. (%)] | <0.001 | |||||
Missing | 229 (21) | 3 (1) | 143 (26) | 75 (17) | 8 (9) | |
<1,000 | 88 (8) | 1 (8) | 36 (7) | 42 (9) | 9 (10) | |
1,000-10,000 | 200 (18) | 0 (0.0) | 89 (16) | 91 (20) | 20 (22) | |
10,000-100,000 | 435 (40) | 6 (46) | 194 (36) | 185 (41) | 50 (54) | |
≥100,000 | 145 (13) | 3 (23) | 81 (15) | 55 (12) | 6 (6) | |
Time to first CD4 count, days | 37.1 (25.9) | 23.5 (18.9) | 37.2 (27.3) | 37.2 (24.9) | 37.6 (23.1) | 0.30 |
No. of immune cell counts available (out of 8), median (IQRe) | 7 (7-7) | 7 (7-7) | 7 (7-7) | 7 (7-7) | 7 (7-7) |
Baseline is within −30 to +183 days of the documented HIV-positive date.
Values are represented as mean (standard deviation) for continuous values and number (percentages) for categorical variables unless otherwise stated.
Cohort sizes were as follows: total, n = 1,097; underweight, n = 13; normal, n = 543; overweight, n = 448; obese, n = 93.
P value calculated from analysis of variance for continuous variables or chi-square test for categorical variables.
IQR, interquartile range.